Everything tagged "medical distribution" across the TickerSpark archives.
McKesson Corporation (MCK) rose after beating EPS and revenue estimates, but the real story goes beyond the headline. This deep-dive examines segment drivers, guidance, cash flow, shareholder returns, and the Medical-Surgical separation to show why the quarter strengthened the forward outlook.
McKesson posted double-digit fiscal 2026 growth, led by oncology, multispecialty, and prescription technology services. The stock earns a Buy, but valuation and a leveraged balance sheet keep the upside more measured.
McKesson Corporation (MCK) rises 7.2% after reporting earnings beats, as investors react to stronger-than-expected results and improved outlook for the healthcare distributor.
Cencora, Inc. (COR) posted a clean earnings beat, with EPS and revenue topping estimates and shares gaining 3.41%. This deep-dive examines segment performance, margin drivers, updated guidance, and what the result says about the company’s operating momentum and valuation backdrop.
Cencora, Inc. (COR) gains 3.2% after posting earnings beats, lifting shares as investors react to stronger-than-expected quarterly results.
Cencora posted 7.5% adjusted EPS growth in Q2 and raised full-year guidance, with specialty pharmaceuticals and international healthcare driving the upside. Thin margins and higher debt keep the story balanced, but the stock still screens as a Buy.
Cencora, Inc. (COR) slumps after missing on EPS and revenue, but the full story goes beyond the headline. This deep-dive unpacks U.S. Healthcare Solutions pressure, international strength, margin shifts, and why raised EPS guidance couldn’t offset a revenue reset.
Cencora, Inc. (COR) slumps 17.4% after reporting earnings misses, as investors react to weaker-than-expected results and pressure on the stock.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime